Jasper Therapeutics, Inc. · NASDAQ:JSPR
Velan Capital Investment Management LP reported a 9.90% stake in Jasper Therapeutics, Inc. (Schedule 13G)
Event Aug 17, 2026 · Filed Aug 17, 2026
Velan Capital Investment Management LP reported a 9.90% stake in Jasper Therapeutics, Inc., 3,363,347 shares, as a passive investor on Aug 17, 2026. Filed Aug 17, 2026 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 3,363,347
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 12 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Velan Capital Master Fund LP | 8.90% | 3,037,776 |
| Velan Capital Holdings LLC | 8.90% | 3,037,776 |
| Velan Horizon Fund LP | 0.20% | 82,008 |
| Velan Horizon GP LLC | 0.20% | 82,008 |
| Avego Healthcare Capital, L.P. | 0.70% | 243,563 |
| Avego Healthcare Capital Holdings, LLC | 0.70% | 243,563 |
| Avego Management LLC | 0.70% | 243,563 |
| Velan Capital Investment Management LP | 9.90% | 3,363,347 |
| Velan Capital Management LLC | 9.90% | 3,363,347 |
| Morgan Adam | 9.90% | 3,363,347 |
| VENKATARAMAN BALAJI | 9.90% | 3,363,347 |
| Kapoor Vishal | 0.10% | 35,013 |
Source
Related
- Jasper Therapeutics, Inc.
- Velan Capital Investment Management LP
- Jasper Therapeutics, Inc. shareholders
- Schedule 13D/A · Velan Capital Investment Management LP · Jul 20, 2026
- Schedule 13D/A · Velan Capital Investment Management LP · Sep 23, 2025
- Schedule 13G/A · Millennium Management LLC · Jul 10, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Schedule 13G/A · Goldman Sachs Group Inc · May 8, 2026
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · May 8, 2026
- Schedule 13G · Millennium Management LLC · Feb 25, 2026